Tankyrase 1 Inhibitors with Drug-like Properties Identified by Screening a DNA-Encoded Chemical Library. Read more about Tankyrase 1 Inhibitors with Drug-like Properties Identified by Screening a DNA-Encoded Chemical Library.
MemProtMD: Automated Insertion of Membrane Protein Structures into Explicit Lipid Membranes. Read more about MemProtMD: Automated Insertion of Membrane Protein Structures into Explicit Lipid Membranes.
Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2. Read more about Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2.
Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. Read more about Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies.
Biochemical characterization of FIKK8-a unique protein kinase from the malaria parasite Plasmodium falciparum and other apicomplexans. Read more about Biochemical characterization of FIKK8-a unique protein kinase from the malaria parasite Plasmodium falciparum and other apicomplexans.
Structural Basis for the Specificity of Human NUDT16 and Its Regulation by Inosine Monophosphate. Read more about Structural Basis for the Specificity of Human NUDT16 and Its Regulation by Inosine Monophosphate.
Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation. Read more about Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation.
Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies. Read more about Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
